SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biomatrix (BXM) Looking Great
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John McCarthy who wrote (292)12/22/1997 5:33:00 PM
From: John McCarthy  Read Replies (1) of 569
 
Ugh .............................................

While back I posted that there was an Arthritis center located
in Missouri that was the Control Center for 7 Regional Sites
located in 7 Central states.

I sent an EMail asking if they used Synvisc.

Below is there reply.

=================================================================

Date:Mon, 22 Dec 1997 15:04:53 -0600
From: Susan_Hazelwood@mailsvr.hsc.missouri.edu (Susan Hazelwood)
To:John McCarthy <decaid@IDT.NET>


Hi John,

I am not sure if any of the regional arthritis centers
are using Syvvisc for treatment of OA. We have not
started doing so here at the Central MO Regional
Arthritis Center in Columbia.

Treatment with such a product requires a
series of five (or so) consecutive weekly shots.
Each shot costs over $100.
Shots have to be repeated every couple of years.

Some rheumatologists are excited about this treatment.
Others feel that the success rate isn't high enough.
We don't really see enough people w/ OA to offer it as a procedure here at this time.

Best wishes.
Susan Hazelwood, Research Associate
University of Missouri Arthritis Center
Columbia, MO 65212
susan_hazelwood@mailsvr.hsc.missouri.edu


______________________________ Reply Separator _________________________________
Subject: SYNVISC for O/A
Author: John McCarthy <decaid@IDT.NET> at umhc-Internet
Date: 12/7/97 11:36 AM


I was wondering if any of the Regional Centers have any
experience with a new treatment for O/A.

It is a product called SYNVISC which was approved by the
FDA in August. It is my understanding that it has been
used successfully in Canada for a couple of years with
a success rate somewhere between 70-85%.

Not sure of the real facts though.

Regards,

John McCarthy
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News